News
Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...
Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In ...
The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...
Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...
Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the ...
1d
RSVP Live on MSNArmagh's Niall Grimley found colitis diagnosis hard: 'It took me years to accept the disease'Gogglebox Ireland star Sarah Reilly, from Dundalk, Co. Louth, was diagnosed with Crohn’s disease in 2017 and she opened up ...
J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...
9d
MedPage Today on MSNAppendectomy Reduced Relapse Rates in Ulcerative ColitisAppendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...
The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...
A study published in The Lancet suggests that removing the appendix may reduce the risk of relapse in patients with ulcerative colitis. The research shows a significant reduction in relapse rates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results